$498 Million is the total value of SABBY MANAGEMENT, LLC's 103 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 295.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | BIOGEN INCput | $68,065,000 | – | 2,544 | +100.0% | 13.66% | – | |
| New | BIOGEN INCcall | $48,266,000 | – | 1,804 | +100.0% | 9.69% | – | |
| Buy | BRAINSTORM CELL THERAPEUTICSput | $33,173,000 | +1669.2% | 9,329 | +130.9% | 6.66% | +754.8% | |
| BIIB | New | BIOGEN INC | $27,799,000 | – | 103,902 | +100.0% | 5.58% | – |
| Buy | SPDR SERIES TRUSTput | $25,894,000 | +89.0% | 2,313 | +30.8% | 5.20% | -8.7% | |
| New | MODERNA INCput | $18,717,000 | – | 2,915 | +100.0% | 3.76% | – | |
| Buy | SPDR S&P 500call | $17,299,000 | +100.9% | 561 | +68.0% | 3.47% | -3.0% | |
| Buy | ISHARES RUSSELL 2000call | $15,034,000 | +241.1% | 1,050 | +172.7% | 3.02% | +64.8% | |
| Buy | ISHARES NASDAQ BIOTECHput | $14,393,000 | +108.1% | 1,053 | +64.0% | 2.89% | +0.5% | |
| XLV | Buy | SECTOR HEALTHCAREetf | $10,535,000 | +245.6% | 105,280 | +206.0% | 2.12% | +66.9% |
| New | INOVIO PHARMACEUTICALScall | $6,721,000 | – | 2,494 | +100.0% | 1.35% | – | |
| Buy | SORRENTO THERAPEUTICS INCput | $6,331,000 | +2090.7% | 10,081 | +542.5% | 1.27% | +959.2% | |
| New | INOVIO PHARMACEUTICALSput | $5,821,000 | – | 2,160 | +100.0% | 1.17% | – | |
| Buy | FIBROGEN INCput | $5,703,000 | +354.8% | 1,407 | +289.8% | 1.14% | +119.8% | |
| Buy | PLURISTEM THERAPEUTICSput | $5,425,000 | +606.4% | 6,137 | +193.2% | 1.09% | +241.4% | |
| MRNA | New | MODERNA INC | $4,616,000 | – | 71,893 | +100.0% | 0.93% | – |
| Buy | CEL-SCI CORPput | $4,601,000 | +77.0% | 3,084 | +36.9% | 0.92% | -14.4% | |
| New | ASTRAZENECA PLCput | $3,570,000 | – | 675 | +100.0% | 0.72% | – | |
| New | SORRENTO THERAPEUTICS INCcall | $3,237,000 | – | 5,155 | +100.0% | 0.65% | – | |
| Buy | ALTIMMUNE INCput | $3,062,000 | +1690.6% | 2,859 | +435.4% | 0.62% | +766.2% | |
| New | CEL-SCI CORPcall | $2,923,000 | – | 1,959 | +100.0% | 0.59% | – | |
| XERS | New | XERIS PHARMACEUTICALS | $2,889,000 | – | 1,086,031 | +100.0% | 0.58% | – |
| PLL | New | PIEDMONT LITHIUM LTD | $2,875,000 | – | 498,259 | +100.0% | 0.58% | – |
| CRIS | New | CURIS INC | $2,743,000 | – | 2,267,068 | +100.0% | 0.55% | – |
| ALNA | New | ALLENA PHARMACEUTICALS | $2,420,000 | – | 1,531,446 | +100.0% | 0.49% | – |
| New | NIKOLA CORPput | $2,330,000 | – | 345 | +100.0% | 0.47% | – | |
| Buy | AVEO PHARMACEUTICALS INCcall | $2,191,000 | +43.1% | 4,255 | +0.6% | 0.44% | -30.8% | |
| Buy | ODONATE THERAPEUTICS INCput | $2,011,000 | +63.6% | 475 | +6.7% | 0.40% | -20.9% | |
| NRBO | New | NEUROBO PHARMACEUTICALS | $1,872,000 | – | 232,547 | +100.0% | 0.38% | – |
| Buy | TRILLIUM THERAPEUTICScall | $1,840,000 | +355.4% | 2,275 | +127.5% | 0.37% | +119.6% | |
| AZN | New | ASTRAZENECA PLCadr | $1,657,000 | – | 31,320 | +100.0% | 0.33% | – |
| FGEN | New | FIBROGEN INC | $1,360,000 | – | 33,560 | +100.0% | 0.27% | – |
| CVM | Buy | CEL-SCI CORP | $1,319,000 | +107.7% | 88,417 | +60.7% | 0.26% | +0.4% |
| GLBS | New | GLOBUS MARITIME LTD | $1,275,000 | – | 4,776,735 | +100.0% | 0.26% | – |
| IBB | New | ISHARES NASDAQ BIOTECHetf | $1,248,000 | – | 9,130 | +100.0% | 0.25% | – |
| NKLAW | New | NIKOLA CORP*w | $1,145,000 | – | 34,500 | +100.0% | 0.23% | – |
| New | CELLDEX THERAPEUTICS INCcall | $1,017,000 | – | 782 | +100.0% | 0.20% | – | |
| New | MODERNA INCcall | $1,015,000 | – | 158 | +100.0% | 0.20% | – | |
| New | IONIS PHARMACEUTICALSput | $991,000 | – | 168 | +100.0% | 0.20% | – | |
| CLDX | New | CELLDEX THERAPEUTICS INC | $950,000 | – | 73,094 | +100.0% | 0.19% | – |
| New | ODONATE THERAPEUTICS INCcall | $944,000 | – | 223 | +100.0% | 0.19% | – | |
| SCPH | New | SCPHARMACEUTICALS INC | $926,000 | – | 125,752 | +100.0% | 0.19% | – |
| SOLY | New | SOLITON INC | $800,000 | – | 102,891 | +100.0% | 0.16% | – |
| NVCN | New | NEOVASC INC | $776,000 | – | 326,023 | +100.0% | 0.16% | – |
| MBIO | New | MUSTANG BIO INC | $747,000 | – | 234,778 | +100.0% | 0.15% | – |
| New | IONIS PHARMACEUTICALScall | $731,000 | – | 124 | +100.0% | 0.15% | – | |
| AVGR | Buy | AVINGER INC | $676,000 | +186.4% | 2,183,464 | +284.1% | 0.14% | +38.8% |
| IMUX | New | IMMUNIC INC | $642,000 | – | 53,009 | +100.0% | 0.13% | – |
| Buy | GENOCEA BIOSCIENCES INCcall | $489,000 | +136.2% | 2,126 | +77.0% | 0.10% | +14.0% | |
| YTRA | New | YATRA ONLINE INC | $441,000 | – | 650,000 | +100.0% | 0.09% | – |
| Buy | TRILLIUM THERAPEUTICSput | $426,000 | +134.1% | 527 | +16.9% | 0.09% | +13.2% | |
| GNPX | New | GENPREX INC | $372,000 | – | 118,584 | +100.0% | 0.08% | – |
| New | CYTOKINETICS INCcall | $370,000 | – | 157 | +100.0% | 0.07% | – | |
| New | PREDICTIVE ONCOLOGY INC | $367,000 | – | 223,540 | +100.0% | 0.07% | – | |
| ATNM | Buy | ACTINIUM PHARMACEUTICALS | $342,000 | +182.6% | 972,285 | +56.4% | 0.07% | +38.0% |
| New | CATABASIS PHARMSput | $306,000 | – | 476 | +100.0% | 0.06% | – | |
| AIKI | New | AIKIDO PHARMA INC | $281,000 | – | 342,121 | +100.0% | 0.06% | – |
| New | CELSION CORPcall | $243,000 | – | 653 | +100.0% | 0.05% | – | |
| XBI | New | SPDR SERIES TRUSTetf | $241,000 | – | 2,150 | +100.0% | 0.05% | – |
| RKDA | New | ARCADIA BIOSCIENCES INC | $224,000 | – | 59,543 | +100.0% | 0.04% | – |
| New | ALTIMMUNE INCcall | $202,000 | – | 189 | +100.0% | 0.04% | – | |
| New | BAUDAX BIO INCput | $190,000 | – | 459 | +100.0% | 0.04% | – | |
| HOTH | New | HOTH THERAPEUTICS INC | $177,000 | – | 68,681 | +100.0% | 0.04% | – |
| New | XPRESSPA GROUP INCput | $141,000 | – | 337 | +100.0% | 0.03% | – | |
| BNTC | New | BENITEC BIOPHARMA INC | $94,000 | – | 11,863 | +100.0% | 0.02% | – |
| New | REMARK HOLDINGS INCput | $97,000 | – | 413 | +100.0% | 0.02% | – | |
| New | ENERGY FOCUS INCput | $83,000 | – | 120 | +100.0% | 0.02% | – | |
| MARK | New | REMARK HOLDINGS INC | $80,000 | – | 33,953 | +100.0% | 0.02% | – |
| CJJD | New | CHINA JO JO DRUGSTORES | $69,000 | – | 50,000 | +100.0% | 0.01% | – |
| New | CATABASIS PHARMScall | $65,000 | – | 101 | +100.0% | 0.01% | – | |
| New | CELSION CORPput | $54,000 | – | 145 | +100.0% | 0.01% | – | |
| INO | New | INOVIO PHARMACEUTICALS | $54,000 | – | 2,000 | +100.0% | 0.01% | – |
| New | TRANSENTERIX INCput | $43,000 | – | 794 | +100.0% | 0.01% | – | |
| New | LM FUNDING AMERICA INC | $34,000 | – | 25,000 | +100.0% | 0.01% | – | |
| New | POLARITYTE INCput | $25,000 | – | 200 | +100.0% | 0.01% | – | |
| LPCN | New | LIPOCINE INC NEW | $18,000 | – | 14,452 | +100.0% | 0.00% | – |
| PULM | New | PULMATRIX INC | $21,000 | – | 11,944 | +100.0% | 0.00% | – |
| NSPR | Buy | INSPIREMD INC | $22,000 | +214.3% | 48,300 | +337.7% | 0.00% | +33.3% |
| New | LIPOCINE INC NEWput | $13,000 | – | 100 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 40 | Q2 2024 | 49.1% |
| ISHARES TR | 38 | Q2 2024 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| ISHARES TR | 20 | Q2 2024 | 12.7% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyngn Inc. | January 04, 2024 | 5,322,048 | 10.0% |
| iBio, Inc. | January 04, 2024 | 200,303 | 10.0% |
| InMed Pharmaceuticals Inc. | January 04, 2024 | 524,972 | 10.0% |
| Phunware, Inc. | January 04, 2024 | 10,006,584 | 5.9% |
| TREASURE GLOBAL INC | January 04, 2024 | 5,338,587 | 10.0% |
| Arcadia Biosciences, Inc. | January 03, 2024 | 97,305 | 8.8% |
| Bluejay Diagnostics, Inc. | January 03, 2024 | 177,513 | 10.0% |
| Fangdd Network Group Ltd. | January 03, 2024 | 600,427 | 10.0% |
| GlucoTrack, Inc. | January 03, 2024 | 2,087,130 | 10.0% |
| LIPELLA PHARMACEUTICALS INC. | January 03, 2024 | 579,814 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-04 |
| 4 | 2024-09-03 |
| 4 | 2024-08-30 |
| 4 | 2024-08-28 |
| 4 | 2024-08-26 |
| 4 | 2024-08-22 |
| 4 | 2024-08-20 |
| 4 | 2024-08-16 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-08-14 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.